Full metadata record
DC FieldValueLanguage
dc.contributor.authorLiu, Yuan-Tingen_US
dc.contributor.authorHu, Tain-Changen_US
dc.contributor.authorChang, Cheng-Hsiangen_US
dc.contributor.authorShie, Wen-Shiangen_US
dc.contributor.authorWu, Tung-Kungen_US
dc.date.accessioned2014-12-08T15:28:12Z-
dc.date.available2014-12-08T15:28:12Z-
dc.date.issued2012-10-19en_US
dc.identifier.issn1523-7060en_US
dc.identifier.urihttp://dx.doi.org/10.1021/ol302341hen_US
dc.identifier.urihttp://hdl.handle.net/11536/20423-
dc.description.abstractA Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase mutant, ERG7(T384Y/Q450H/V4541), produced parkeol but not lanosterol as the sole end product. Parkeol undergoes downstream metabolism to generate compounds 9 and 10. In vitro incubation of parkeol produced a product profile similar to that of the in vivo experiment. In summary, parkeol undergoes a metabolic pathway similar to that of cycloartenol in yeast but distinct from that of lanosterol in yeast, suggesting that two different metabolic pathways of postoxidosqualene cyclization may exist in S. cerevisiae.en_US
dc.language.isoen_USen_US
dc.titleProtein Engineering of Saccharomyces cerevisiae Oxidosqualene-Lanosterol Cyclase into Parkeol Synthaseen_US
dc.typeArticleen_US
dc.identifier.doi10.1021/ol302341hen_US
dc.identifier.journalORGANIC LETTERSen_US
dc.citation.volume14en_US
dc.citation.issue20en_US
dc.citation.spage5222en_US
dc.citation.epage5225en_US
dc.contributor.department生物科技學系zh_TW
dc.contributor.departmentDepartment of Biological Science and Technologyen_US
dc.identifier.wosnumberWOS:000309951500015-
dc.citation.woscount1-
Appears in Collections:Articles


Files in This Item:

  1. 000309951500015.pdf

If it is a zip file, please download the file and unzip it, then open index.html in a browser to view the full text content.